A group of Australasian healthcare businesses is advanced when it comes to supply chain innovation.
This claim was made by Packaging Services, Pfizer Inc., at the October launch of the GS1 Australasian Healthcare User Group Local Interest Team (HUGLIT).
Australians are doing a lot of work on eCommerce and with data synchronisation is the advantage of using clean data. If one continues doing all this great work in a timely manner at the market level, they are the leaders. If they have developed a successful model and have great success stories, then why would not they allow the rest of the world to leverage that? That will be the benefit of the HUGLIT, a direct link to influential healthcare retailers, hospitals, regulatory bodies, wholesalers, distributors and manufacturers.
According to GS1 Global Healthcare User Group (HUG), Europe and the USA could learn a lot about how Australasia is using the GS1 System.
The Australasian HUGLIT will give Australia and New Zealand’s work global exposure. Any market around the world has a lot to learn about what GS1 and the Healthcare sector is doing here.
Driven jointly by GS1 Australia and GS1 New Zealand, the Australasian HUGLIT will work together with participants of the HUG, which includes 3M, B. Braun, Baxter, GSK, Johnson & Johnson, Novartis, Pfizer, Procter & Gamble, and Wyeth among others. The HUG has a mission to lead the healthcare industry to the effective utilisation and development of the GS1 System to improve patient safety. The initial primary focus for the group is automatic identification using GS1 Standards for numbering structures and data carriers (e.g. bar codes and radio frequency identification).
According to GS1, while aligning with the HUG focus, the HUGLIT will also undertake Australasian specific work areas as Australia and New Zealand are an important part of the global supply chain. This is an opportunity to provide a local voice, local perspective, and local experience to the global standards process. The HUGLIT is an important step in building a strong channel between GS1 and global industry, so it can have a voice and contribute to how global supply chains are managed.
Reinforcing this desire was the presence of senior representatives from manufacturers of healthcare devices and pharmaceuticals, healthcare wholesalers, government departments, hospitals and tertiary education institutions at the HUGLIT meeting, including 3M, Abbott, CH2, and Welch Allyn.According to Pfizer, it is involved in the Global HUG because it made sound business sense and because it must establish global standards, if the pharmaceutical and medical device supply chain is going to be effective in addressing patient safety concerns when it comes to electronic commerce and automatic identification. With these standards in place, Pfizer should all able to achieve its objectives quicker and with lower overall cost burden.
When it comes to cost burden, while as an industry, Pfizer always try to minimise costs, they also need to be aware of what it will cost the industry if they do no0t take action. The HUG and the HUGLIT work hard to ensure standards around technology are developed based on clearly defined business and user requirements, and not based solely on what hardware or software suppliers believe the solutions to be.